As of 2025-11-11, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -14.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 847.11 mil USD. MRVI's TTM EBITDA according to its financial statements is -57.07 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 14.8x | 13.9x |
| Forward P/E multiples | 17.3x - 24.9x | 19.9x |
| Fair Price | (4.08) - (3.52) | (3.99) |
| Upside | -231.5% - -213.4% | -228.9% |
| Date | EV/EBITDA |
| 2025-11-10 | -14.84 |
| 2025-11-07 | -13.81 |
| 2025-11-06 | -13.90 |
| 2025-11-05 | -13.81 |
| 2025-11-04 | -13.81 |
| 2025-11-03 | -14.13 |
| 2025-10-31 | -15.02 |
| 2025-10-30 | -15.02 |
| 2025-10-29 | -14.71 |
| 2025-10-28 | -15.42 |
| 2025-10-27 | -15.92 |
| 2025-10-24 | -16.23 |
| 2025-10-23 | -16.54 |
| 2025-10-22 | -16.23 |
| 2025-10-21 | -16.05 |
| 2025-10-20 | -16.72 |
| 2025-10-17 | -15.74 |
| 2025-10-16 | -16.59 |
| 2025-10-15 | -16.05 |
| 2025-10-14 | -15.42 |
| 2025-10-13 | -15.74 |
| 2025-10-10 | -15.25 |
| 2025-10-09 | -15.74 |
| 2025-10-08 | -15.87 |
| 2025-10-07 | -15.78 |
| 2025-10-06 | -14.93 |
| 2025-10-03 | -14.80 |
| 2025-10-02 | -14.26 |
| 2025-10-01 | -15.02 |
| 2025-09-30 | -13.81 |
| 2025-09-29 | -13.63 |
| 2025-09-26 | -13.59 |
| 2025-09-25 | -13.01 |
| 2025-09-24 | -13.14 |
| 2025-09-23 | -13.23 |
| 2025-09-22 | -13.28 |
| 2025-09-19 | -13.05 |
| 2025-09-18 | -13.86 |
| 2025-09-17 | -13.54 |
| 2025-09-16 | -13.90 |
| 2025-09-15 | -13.14 |
| 2025-09-12 | -12.92 |
| 2025-09-11 | -13.46 |
| 2025-09-10 | -12.61 |
| 2025-09-09 | -12.87 |
| 2025-09-08 | -11.89 |
| 2025-09-05 | -12.20 |
| 2025-09-04 | -11.53 |
| 2025-09-03 | -11.53 |
| 2025-09-02 | -11.58 |